drugset / Trial / NCT00594620

Soy Derivatives for Control of Hot Flashes in Men on Androgen Deprivation Therapy

NCT00594620 ↗

Phase 2 Terminated 11 enrolled University of Kansas Medical Center Amgen · collab
RandomizedSingle-groupDouble-blindTreatment

Summary

To determine the efficacy of soy/isoflavone supplementation on hot flashes in men who are being treated with luteinizing hormone-releasing hormone (LHRH) agonist therapy for control of advanced prostate cancer

Timeline

Start
2004-08
Primary completion
2010-04
Completion
2010-04

Outcome

Outcome not reported

Stopped (Enrollment): “Terminated due to poor accrual and without sufficient patients or data to report on any outcomes.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Flav-ein Unknown — —

Indications